A phase I randomized, placebo-controlled, alternating-panel, single-rising IV dose study of SCY-078 in healthy subjects

Trial Profile

A phase I randomized, placebo-controlled, alternating-panel, single-rising IV dose study of SCY-078 in healthy subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Aug 2016

At a glance

  • Drugs SCY 078 (Primary) ; SCY 078 (Primary)
  • Indications Mycoses
  • Focus Adverse reactions
  • Most Recent Events

    • 08 Aug 2016 Results from this trial are expected in November 2016, according to a SCYNEXIS media release.
    • 20 Jun 2016 Interim sub-analysis (n=14) from this trial were presented at ASM Microbe 2016, according to a Scynexis media release.
    • 20 Jun 2016 Results (n=14) published in a Scynexis media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top